Sign Up to like & get
recommendations!
1
Published in 2020 at "Archives of Clinical Neuropsychology"
DOI: 10.1093/arclin/acaa068.04
Abstract: Apolipoprotein (ApoE)-e4 is well established as a genetic risk factor for Alzheimer’s disease (AD) as well as a predictor for the rate of cognitive decline in AD. Among older adults without dementia, some research has…
read more here.
Keywords:
non carriers;
non demented;
older adults;
status cognition ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Molecular Autism"
DOI: 10.1186/s13229-020-00356-z
Abstract: Background A crucial step to understanding the mechanistic underpinnings of autism spectrum disorder (ASD), is to examine if the biological underpinnings of ASD in genetic high-risk conditions, like 22q11.2 deletion syndrome (22q11.2DS), are similar to…
read more here.
Keywords:
symptomatology;
22q11 2ds;
autism;
non carriers ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2023.1100322
Abstract: Background and objectives Among individuals with Alzheimer's disease (AD), APOE e4 carriers with increased white matter hyperintensities (WMHs) may selectively be at increased risk of cognitive impairment. Given that the cholinergic system plays a crucial…
read more here.
Keywords:
white matter;
carriers non;
dementia severity;
cholinergic pathways ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Catalysts"
DOI: 10.3390/catal9080647
Abstract: Immobilization techniques are generally based on reusing enzymes in industrial applications to reduce costs and improve enzyme properties. These techniques have been developing for decades, and many methods for immobilizing enzymes have been designed. To…
read more here.
Keywords:
enzyme properties;
recent developments;
carriers non;
immobilization ... See more keywords